Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
6 US States for Fly Fishing01.01.1 - 2The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices17.10.2023
- 37 Methods for further developing Rest Quality06.06.2024
- 4One perk to marrying Richard Marx later in life? 'We don't have time' for stupid arguments, says Daisy Fuentes.27.11.2025
- 5Watch SpaceX launch powerful ocean-mapping satellite for Europe and NASA early Nov. 1716.11.2025
- Europe pledges over €15bn for clean energy for Africa
- Solar storms have influenced our history – an environmental historian explains how they could also threaten our future
- RFK Jr. guts the US childhood vaccine schedule despite its decades-long safety record
- Get To Be familiar with The Historical backdrop Of Western Medication
- The most effective method to Shake Hands During a Pandemic: Wellbeing Tips and Behavior
- Nuno Loureiro, MIT physicist, fatally shot at home; police investigate
- Figure out How to Get a good deal on Your Rooftop Substitution Venture
- New law puts familiar drinks, creams and gummies in legal limbo
- Russia accidentally destroys its only way of sending astronauts to space
